No Cancer Risk From Long-Acting Insulin: Studies

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Three studies should squelch fears that taking a form of insulin called insulin glargine (Lantus) increases the risk of cancer, researchers say.

Prior research had suggested an increase in cancer risk with Lantus, an injectable drug used to treat diabetes. "But, the worry we had that Lantos might be associated with cancer seems not to be the case, and people should continue using insulin," said Dr. Spyros Mezitis, an endocrinologist at Lenox Hill Hospital in New York City, who wasn't involved in these studies.

http://www.philly.com/philly/health...-Acting_Insulin__Studies.html?cmpid=138896554
 
Status
Not open for further replies.
Back
Top